ICAM1 and lung carcinoma: Regarding the underlying mechanisms, one investigation demonstrated increased ICAM-1 expression as a cause of the antimetastatic effect of CBD on lung cancer cells, with the effect being reversed by an ICAM-1 neutralising antibody [93].